PPT Slide

Antiviral activity of HPMPC first described in 1987

Licensed for clinical use for the treatment of CMV retinitis

in AIDS patients in June 1996.

E. De Clercq, T. Sakuma, M. Baba, R. Pauwels, J. Balzarini,

I. Rosenberg & A. Holư.

Antiviral activity of phosphonylmethoxyalkyl derivatives

of purine and pyrimidines.

Antiviral Res. 8, 261-272 (1987).

Previous slide

Next slide

Back to first slide

View graphic version